These or other visual impairments, according to the who, suffers almost every fifth inhabitant of our planet. Diseases associated with visual impairment can be fairly harmless (for example, all known myopia) and difficult therapy, and even leading to complete blindness. To the latter category of age-related macular degeneration. But, according to the publication Science Daily, was invented drops, which will help to cope with this disease.
At the moment, as a therapy applied regular monthly injection in the rear chamber of the eye for at least three years. Herself as age-related macular degeneration (abbreviated AMD) is a violation that occurs in the center of the retina, in the so-called macula, the structure of the eye responsible for visual acuity necessary for reading, driving and performing other activities that requires clear and sharp vision.
Scientists have created a drug in the form of drops capable of delivering penetrating peptides (CPP) in damaged areas of the eye. According to them, the new eye drops are as effective as the injectable form of the drug. Says study author Dr. felicity de Cogan, their development is more convenient and a much safer method of drug delivery. Because injections are not only painful, but can cause tearing of eye tissue, infection and even increase the risk of blindness.
The researchers believe that drugs with CPP have a high potential for treating other ophthalmic diseases that require the delivery of the drug into the posterior chamber of the eye.
Developed eye drops for the treatment of age-related blindness
Vladimir Kuznetsov